Section 22-2A-1 Legislative findings. The Legislature of Alabama finds that the high cost of pharmaceuticals is a matter of much concern to this state, especially as the cost and utilization of drug therapy continues to rise. Insofar as this rise represents a trend towards drug therapy in lieu of more invasive and expensive procedures, it […]
Section 22-2A-2 Definitions. As used in this chapter the following terms shall have the following meanings: (1) MULTI-STATE POOLING INITIATIVE. A group of two or more states working together to reduce the cost of pharmaceuticals purchased or paid for by those states. (2) PHARMACEUTICAL or DRUG. Any medicinal substance, preparation, or device recognized by the […]
Section 22-2A-3 Program and procedures; exceptions; competitive bidding. (a) The State Health Officer may develop, maintain, and implement a program and procedures to do the following: (1) Aggregate or negotiate the purchase of pharmaceuticals for pharmaceutical programs for state agencies, as defined herein, or joining a multi-state pooling initiative, or both, and (2) maximize savings, […]
Section 22-2A-4 Applicability of chapter. Notwithstanding any other provision of law to the contrary, pharmaceutical programs as defined herein shall obtain drugs through the program established pursuant to this chapter, unless a particular pharmaceutical program can purchase its pharmaceuticals at a special rate, which is lower than the savings and rebates that could be realized […]
Section 22-2A-5 Access to medications by certain clients. Negotiations pursuant to subdivision (1) of subsection (a) of Section 22-2A-3 shall not restrict access to medications required by clients served by the Department of Mental Health. (Act 2002-494, p. 1262, §5.)
Section 22-2A-6 Medicaid Agency exempt. The Medicaid Agency shall be exempt from this chapter. (Act 2002-494, p. 1262, §6.)
Section 22-2A-7 Disposition of funds. All rebates and savings specifically realized shall be deposited in the General Fund of the state. (Act 2002-494, p. 1262, §7.)
